Top 6 Singapore Dividend Stocks 2025

简要总结

本视频介绍了新加坡最值得投资的六只高股息股票,并分析了它们的优势、风险和估值。

  • 新加坡银行(DBS、UOB、OCBC):股息稳定增长,财务状况良好,具有强大的竞争优势,但目前估值偏高。
  • 新加坡交易所(SGX):股息支付稳定增长,收入来源多元化,但面临日益激烈的竞争和上市公司质量问题。
  • 昇菘集团(Sheng Siong):股息持续增长,财务状况良好,具有抗衰退能力,但运营利润率较低。
  • 百汇生命房地产投资信托(Parkway Life REIT):股息持续增长,投资组合具有防御性,租赁期限长,但面临货币风险。
  • 丰树工业信托(Mapletree Industrial Trust):股息稳定增长,投资组合以数据中心和高科技工业地产为主,但面临数据中心空置率上升和借贷成本上升的风险。
  • 新科工程(ST Engineering):股息支付稳定,订单量大幅增加,财务状况良好,但股息增长相对温和。

简介

视频介绍了新加坡六只最佳股息股票,包括新加坡银行、新加坡交易所、昇菘集团、百汇生命房地产投资信托、丰树工业信托和新科工程。

新加坡银行

新加坡的三家银行(星展银行、大华银行和华侨银行)都是优秀的银行,符合优秀股息股票的三个标准:股息支付稳定增长(2020年除外),股息增长有强大的财务状况支持,以及具有持久的竞争优势。这三家银行控制着新加坡的大部分国内存款和贷款,具有显著的定价权和运营规模。同时,它们也在稳步扩大海外业务,以提供新的增长引擎。尽管银行是优秀的股息股票,但估值仍然重要。目前,所有三家银行的市净率都高于历史平均水平,这增加了下行风险。因此,最好等待更具吸引力的入场点。

新加坡交易所

新加坡交易所(SGX)也是另一家强大的股息支付公司,拥有持续股息支付的记录,并且多年来稳步增加。更重要的是,截至去年,它维持了约60%以上的可持续派息率,表明其股息得到了盈利的良好支持。新加坡交易所的收入、净利润和自由现金流多年来一直在可靠地上升,并且享有接近50%的运营利润率。其收入来源几乎平均分配在现金股票、衍生品、固定收益和平台相关费用上。这种多元化有助于新加坡交易所在不同的市场条件下维持稳定的盈利,同时减少对任何单一业务部门的依赖。然而,尽管如此,新加坡交易所目前正面临一些问题。首先,新加坡交易所正面临日益激烈的竞争。过去五年,在新加坡交易所上市的公司数量下降了约20%,而马来西亚交易所同期继续吸引更多上市公司。最重要的是,新加坡交易所的上市公司质量也一直令人担忧。目前,约有8%的新加坡交易所上市公司处于停牌状态,而只有70%的主板公司盈利,而凯利板公司只有43%。更令人震惊的是,86%的凯利板股票目前的交易价格低于其首日收盘价,其中40%的股票几乎损失了所有初始价值。新加坡金融管理局(MAS)已经意识到这些挑战,并推出了一系列措施来振兴新加坡市场。虽然恢复零售投资者的信任和信心仍然是一个尚未完全解决的领域。虽然新加坡交易所仍然是一只可靠的股息支付股票,但其目前的股价似乎略高于其估值。

昇菘集团

昇菘集团(Sheng Siong)在持续增加股息方面也有非常出色的记录。其股息支付不仅逐年增长,而且还得到了约70%的可持续派息率的良好支持。这当然是由于其强大的财务状况,昇菘集团能够可靠地增加其收入、净利润以及多年来的自由现金流。他们是如何做到的?他们通过不断在新加坡的住宅区开设新店来实现这一目标。他们目前在中国也有6家商店,尽管这只占他们总收入的一小部分。他们的运营利润率有点低,为10%,但这在实体零售商中相当普遍。昇菘集团除了其稳步增长的财务状况外,最棒的一点是它实际上相当抗衰退。这是因为无论如何人们仍然需要购买杂货。事实上,从我们所看到的,在危机时期,由于人们急于储备卫生纸和方便面,昇菘集团可以表现得非常好。即使在新加坡还有许多其他杂货店,如职总平价、巨人超市、冷藏公司和各种在线平台,昇菘集团仍然设法保持竞争力。它通过清晰的物有所值的定位、高效的运营和忠实的客户群来实现这一目标。至于其估值,分析师目前给该股的平均目标价约为1.89美元,表明可能仍有一些上涨潜力。同样,GuruFocus等估值工具表明该股的交易价格接近其公允价值。

百汇生命房地产投资信托

百汇生命房地产投资信托(Parkway Life REIT)是少数几家多年来持续派发增长股息的新加坡房地产投资信托之一。这一强劲表现主要归功于其医疗保健资产的防御性投资组合,并得到包括内置租金递增的长期租赁的支持。例如,虽然像凯德综合商业信托(CICT)等其他房地产投资信托的加权平均租赁到期日(WALE)只有几年,但百汇生命房地产投资信托的WALE为15年。这有助于提供高盈利可见性,降低租赁续约风险,同时确保投资者即使在市场不确定时期也能获得更稳定的收入流,所有这些都清楚地反映在其强大的财务状况中。该房地产投资信托在新加坡拥有三家私立医院,占据了当地私立医疗保健市场的重要份额。它还在日本持有大量疗养院投资组合,并且最近通过收购几家法国疗养院而扩展到法国。因此,进一步多元化到另一个在老年护理领域具有强大基本面的市场。然而,通过扩展到海外市场,该房地产投资信托现在必须面对日元和欧元贬值带来的货币风险。值得庆幸的是,百汇生命房地产投资信托已通过实施一直到2030年的货币对冲来积极管理这一风险。最重要的是,百汇生命房地产投资信托保持谨慎的债务管理。凭借36%的健康杠杆率,它有充足的空间来资助未来的收购或资产增值,而无需承担过多的杠杆。管理层还采取了一种有纪律的债务到期方法,旨在使任何一年到期的总债务不超过30%,以避免集中效应和集中风险。分析师给出的目标价约为4.67美元,这意味着有11%的上涨潜力。然而,值得注意的是,其目前的市净率略高于其历史平均水平,这可能表明该股的定价已经溢价。

丰树工业信托

丰树工业信托(Mapletree Industrial Trust,MIT)的投资组合更具防御性。凯德腾飞房地产投资信托(CapitaLand Ascendas REIT)在办公领域有大量敞口,而凯德综合商业信托(CICT)则持有零售和办公资产的组合,这两种资产通常更容易受到经济状况、消费者行为和不断变化的工作场所趋势的影响。相比之下,MIT的投资组合主要由数据中心和高科技工业地产组成。这些资产类别在经济周期中往往更具弹性,并且可能在不确定的环境中提供更大的稳定性。MIT在稳定和增长的股息方面有着良好的记录。然而,如果查看他们的财务状况,自2021年以来,他们的净收入和自由现金流一直不太好。这不是MIT独有的问题,而是整个房地产投资信托行业的一种趋势,这主要是由于利率上升导致借贷成本上升。分析师预计,由于美国和新加坡数据中心的空置率上升,未来两年该房地产投资信托的收入将下降5-6%,每单位派息将下降4%。此外,他们24%的债务将在今年到期,这可能会进一步推高借贷成本。不过,并非一切都不好。星展银行(DBS)认为,美国数据中心非续约造成的大部分收入损失将在很大程度上被其过去在日本的收购、新的贡献、租金递增以及加冷道资产的持续租赁所弥补。摩根大通(JP Morgan)最近将其目标价下调至1.90美元,但其他分析师继续给出2.30美元至2.60美元的目标价,表明可能仍有上涨潜力。该股目前的交易价格略高于其5年平均市净率,这可能表明其定价略有溢价。

新科工程

新科工程(ST Engineering)是新加坡领先的国防承包商。虽然该公司一直持续派发股息,但多年来派息的增长相对温和。但如果超越股息,基本面将讲述一个更强大的故事。新科工程的订单量几乎翻了一番,从154亿新元增加到285亿新元。在过去几年中,该公司在收入、净利润和自由现金流方面实现了稳定增长,这表明其运营业绩强劲且具有长期潜力。不仅如此,新科工程已经实现了其在2021年制定的五年路线图中的一半目标,并且有望实现剩余目标。与此同时,该公司还公布了一项新的五年战略计划。主要目标包括使集团收入以全球GDP增长率的2.5倍的速度增长,使净利润以高于收入增长率高达5个百分点的速度增长,以及使股息支付与利润增长保持一致,以确保股东直接从其业绩中受益。为此,新科工程已经确定了未来几年的几个关键增长支柱。这些包括商业航空航天收入,预计未来五年将以行业速度的两倍增长;智慧城市解决方案,预计将以全球GDP增长率的3.5倍的速度扩张;以及一个更大的可寻址国际国防市场,目前估计超过110亿美元。分析师已将其目标价提高至7美元左右,该股不仅达到了该水平,而且略有超过。鉴于其强劲的基本面和增长前景,该股目前以溢价交易也就不足为奇了。

几秒总结任意 YouTube 视频

用免费的 Summ App,为任意视频生成这样的摘要,支持你的语言。

在 App Store 下载
在 Google Play 下载

文字稿

“Top 6 Singapore Dividend Stocks 2025”的完整文字稿。点击时间戳即可从该位置打开视频。想要其他视频的字幕?试试 YouTube 字幕提取工具。

0:00 Here are the best 6 dividend stocks in Singapore. I don’t want to waste any of your time, so here are the names: Singapore banks, Singapore Exchange, Sheng Siong, Parkway Life, Mapletree Industrial Trust and ST Engineering. And with that being said, let’s dive right into the first name, Singapore banks. Now, the reason I group this by Singapore banks instead of any one name, is because all 3 banks, DBS, UOB and OCBC are good banks, and they fulfill the 3 criteria that every good dividend stocks should have. First, they have always been paying consistent, growing dividends over the years, except for 2020 of course, because MAS put a dividend cap on Singapore banks. Their payout ratio isn’t too high either, which means their dividend payout is sustainable.

0:46 Second, their dividend growth is backed by strong financials. All 3 of them have been able to consistently grow their earnings, while keeping their non-performing loan ratio low. Not just that, they are well-diversified across different business segments like consumer banking, wealth management, and various fee-based income streams. More importantly, they have been actively working to reduce its reliance on net interest income. A clear sign of this progress is DBS now estimates that their net interest margin sensitivity has now reduced to just SGD4M per basis point change as compared to the previous SGD18M during 2021. This represents a drop of almost 77% in NIM sensitivity, over the past 3 years. Likewise, NIM sensitivity has also decreased by 40% for both OCBC and UOB

1:36 as compared to the previous cycle. Because of that, it is expected each 25 bps Fed rate cut will only reduce Singapore banks’ 2025 earnings by just 1-2%. Third, they have durable competitive advantages, aka strong moat that protects their earnings and market share. In Singapore, these 3 banks alone control the vast majority of domestic deposits and loans, giving them significant pricing power and operational scale. At the same time, they have also been steadily growing their overseas presence, which can help to provide new growth engines, while also helping to reduce reliance on just the Singapore market alone. For example, DBS has expanded into India, Taiwan, and Hong Kong. OCBC has built a strong presence in Malaysia, Indonesia, and Greater China. Meanwhile,

2:26 UOB has been deepening its reach in Southeast Asia through the acquisition of Citibank’s consumer banking businesses in Malaysia, Thailand, Indonesia, and Vietnam. However, just because the banks are great dividend stocks doesn’t always make them a great buy. That’s because valuation still matters, and even the best companies can become poor investments if you overpay for them. And right now, all 3 banks are trading at high price to book ratios when compared to their historical average. This raises the risk of downside surprises, especially if the Fed starts cutting rates more aggressively, or if economic conditions soften in the region. Because of that, it’s probably better to wait for a more attractive entry point, one that offers a healthier balance of both dividend yield and valuation.

3:13 Quick pause, if you are looking for the cheapest broker to start your investing journey, check out Interactive Brokers. It has the lowest fees for stocks, ETFs, options and more. Not just that, Interactive Brokers lets you easily research stocks. Like you want to check out company financials? Neh, here it is. You want to check out analyst ratings, neh, here’s a bunch of them. It even has free technical insights which tells you where the stock might possibly go next. So, sign up to Interactive Brokers today, and let’s get back to the video. Moving on, Singapore Exchange Limited, or SGX is also another strong dividend paying company. It has a track record of consistent dividend payouts that have steadily increased over the years. But more importantly, it maintains a sustainable payout ratio of

4:00 around 60%+ as of last year, indicating that its dividends are well-supported by earnings. You can see that their revenue, net income as well as free cash flow has been reliably going up over the years, and they enjoy close to 50% in operating margins. Their revenue sources are almost evenly split across cash equities, derivatives, fixed income and platform related fees. This diversification helps SGX maintain stable earnings across different market conditions, while reducing reliance on any single business segment. However, despite that, SGX is currently facing a few issues. First, SGX is facing growing competition. The number of companies listed on SGX has dropped by around 20% over the past five years, while Bursa Malaysia has continued to attract more listings during the same period.

4:51 On top of that, the quality of companies on SGX has also been an ongoing concern. About 8% of companies listed on SGX are currently suspended, while only 70% of Mainboard companies are profitable, compared to just 43% for Catalist companies. And even more alarming, 86% of Catalist stocks are now trading below their day-one closing price, with 40% having lost almost all of their initial value. Thankfully, MAS is aware of these challenges and has introduced a series of measures to revitalise the Singapore market. Though, restoring retail investor trust and confidence remains an area that has yet to be fully addressed. And we’ll need to wait for further updates and initiatives in the coming months.

5:36 So, is SGX a buy right now? While it remains a solid dividend-paying stock, its current stock price appears to have run slightly ahead of its valuations. Recent analyst price targets from OCBC and RHB stand at $14.09 and $13.60 respectively, both slightly below SGX’s current share price. Similarly, valuation tools like GuruFocus also indicate that the stock may be slightly overvalued at this point. This suggests that while SGX remains fundamentally strong, the current price may have already reflected much of its near-term upside. For long-term investors seeking steady dividend income, it could still be a worthwhile addition—especially on any price dip. Next up, Sheng Siong. Sheng Siong also has a very strong track record of consistently

6:22 increasing its dividends. Its dividend payouts have not only grown over the years but are also well-supported by a sustainable payout ratio of around 70%. This of course is due to its strong financials, where Sheng Siong is able to reliably grow its revenue, net income as well as free cash flow over the years. How? They do it by constantly opening new stores in housing estates in Singapore. They also currently have 6 stores in China, though it only contributes to only a small part of their total revenue. Their operating margin is a little low at 10%, but this is fairly common among physical retailers. The great thing about Sheng Siong, besides its steadily growing financials, is that it’s actually rather recession proof. That’s because people will still need to buy groceries no matter what. In fact,

7:10 from what we have seen, during times of crisis, Sheng Siong can perform exceptionally well as kiasu people rush to stock up on toilet paper and instant noodles. And even though there are many other groceries in Singapore, such as FairPrice, Giant, ColdStorage and various online platforms, Sheng Siong has managed to remain competitive. And it achieves this through a clear value-for-money positioning, efficient operations, and a loyal customer base. As for its valuation, analysts currently assign the stock a median target price of around $1.89, suggesting there may still be some upside potential. Likewise, valuation tools like GuruFocus indicate that the stock is trading close to its fair value. Moving on, the next name is a REIT, and it’s none other than Parkway Life REIT. Parkway Life is one

7:58 of the few Singapore REITs that has consistently delivered growing dividends over the years. This strong performance is largely thanks to its defensive portfolio of healthcare assets, supported by long-term leases that include built-in rental escalations. For example, while other REITs like CICT have a weighted average lease expiry (WALE) of just a few years, Parkway Life boasts a WALE of 15 years. This helps to provide high earnings visibility, reduce lease renewal risk, while ensuring a more stable stream of income for investors, even during periods of market uncertainty, all of which are clearly reflected in their strong financials. The REIT owns three private hospitals in Singapore, capturing a significant share of the local private healthcare market. It also holds a sizable portfolio of nursing homes in Japan and,

8:46 more recently, expanded into France with the acquisition of several French nursing homes. Thus further diversifying into another market with strong fundamentals in the aged-care sector. However, by expanding into overseas markets, the REIT now has to face currency risk from the depreciating yen and euro. Uh oh. Thankfully, Parkway Life REIT has actively managed this risk by implementing currency hedges put in place all the way till 2030. On top of that, Parkway Life REIT maintains prudent debt management. With a healthy gearing ratio of 36%, it has ample headroom to fund future acquisitions or asset enhancements without taking on excessive leverage. The management also takes a disciplined approach to debt maturity, aiming to keep no more than 30%

9:32 of total debt maturing in any single year, to avoid bunching effects and concentration risk. So, is the stock attractive at this point? Analysts are giving it a target price of around $4.67, which implies an upside potential of 11%. However, it’s worth noting that its current price-to-book ratio is slightly above its historical average, which may suggest the stock is already priced at a premium. As such, investors should carefully consider whether the premium is justified in light of the REIT’s future prospects and broader market conditions. Alright, the next one is Mapletree Industrial Trust. You know, I was actually trying to choose between Mapletree Industrial Trust, Capitaland Integrated Commercial Trust, and Capitaland Ascendas REIT, but in the end I settled with MIT.

10:20 Now, don’t get me wrong — all three REITs are solid and well-managed. However, what sets Mapletree Industrial Trust (MIT) apart is its more defensive portfolio. CapitaLand Ascendas REIT has significant exposure to the office sector, while CICT holds a mix of retail and office assets — both of which are typically more vulnerable to shifts in economic conditions, consumer behavior, and evolving workplace trends. In contrast, MIT’s portfolio is predominantly made up of data centres and high-tech industrial properties. These asset classes tend to be more resilient through economic cycles, and may offer greater stability in uncertain environments. MIT has a strong track record of steady and growing dividends. However, if you look at

11:05 their financials, their net income as well as free cash flow hasn’t been doing so well since 2021. This isn’t a problem unique to MIT, but rather is a trend seen across the REIT sector, largely due to the rise in borrowing costs driven by the higher interest rate environment. Over the next 2 years, analysts expect the REIT to have a 5-6% revenue decline as well as a 4% drop in distribution per unit, due to rising vacancies in data centers across the US and Singapore. And to further add on, 24% of their debt will be maturing this year, which may further drive up the cost of borrowing. However, with that being said, not everything is bad. DBS believes that most of the loss of income from non-renewals for the US data-centers will be largely

11:51 compensated by higher contributions from its past acquisitions in Japan, new contributions, rental escalations and continued lease-up of its asset at Kallang Way. So, is the stock attractive at this point? While JP Morgan has recently lowered its target price to $1.90, other analysts have continued to assign target prices ranging from $2.30 to $2.60, suggesting there may still be upside potential. That said, the stock is currently trading slightly above its 5-year average price-to-book ratio, which could indicate that it's priced at a mild premium. However, given its strong fundamentals and long-term growth potential, any meaningful price dips could be a good buying opportunity for long-term investors. Last but not least, we have ST Engineering — Singapore’s leading defense contractor.

12:40 While the company has been consistent in paying dividends, the growth in payouts has been relatively modest over the years. But if you look beyond the dividends, the fundamentals will tell a stronger story. ST Engineering’s order book has nearly doubled, from $15.4 billion to $28.5 billion. And over the past few years, the company has delivered steady growth in revenue, net profit, and free cash flow, signalling robust operational performance and long-term potential. Not only that — ST Engineering has already achieved half of the targets outlined in its 5-year roadmap set in 2021, and it remains on track to meet the remaining goals. At the same time, the company has unveiled a new 5-year strategic plan. Key targets include growing group revenue at 2.5x the global GDP growth rate, increasing net profit

13:29 at a rate up to 5 percentage points higher than revenue growth, and aligning dividend payouts with profit growth to ensure shareholders benefit directly from its performance. For this, ST Engineering has identified several key growth pillars for the years ahead. These include commercial aerospace revenue, which is expected to grow at twice the industry rate over the next five years; smart city solutions, projected to expand at 3.5 times the global GDP growth rate; and a significantly larger addressable international defense market, now estimated at over $11 billion. So, is ST Engineering stock attractive right now? Analysts have raised their price targets to around $7, and the stock has not only reached that level — it has slightly surpassed it. Given its strong

14:15 fundamentals and growth outlook, it's no surprise that the stock is now trading at a premium. Anyway, that’s all for this video. Hopefully you found this useful. Like, share and subscribe as I’ll be posting new videos every Monday, Wednesday and Friday.

Share

更多视频摘要